SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001250853-18-000112
Filing Date
2018-08-08
Accepted
2018-08-08 18:10:47
Documents
1
Period of Report
2018-08-06

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 4  
1 PRIMARY DOCUMENT primary_doc.xml 4 9672
  Complete submission text file 0001250853-18-000112.txt   11079
Mailing Address 41 SEYON STREET BUILDING 1, SUITE 100 WALTHAM MA 02453
Business Address 41 SEYON STREET BUILDING 1, SUITE 100 WALTHAM MA 02453 7814499560
REPLIGEN CORP (Issuer) CIK: 0000730272 (see all company filings)

IRS No.: 042729386 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 110 W. GEORGE BURNS ROAD SUITE D-4018 LOS ANGELES CA 90048
Business Address
EDDLEMAN ROY T (Reporting) CIK: 0001270264 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-14656 | Film No.: 181002715